BiomarkersHumans
Prognostic utility of p ‐tau217 and tau PET in Alzheimer's disease
AAIC 2025 Abstract
Abstract
Background: Recently proposed biomarker‐based biological staging schemes may improve risk prediction of cognitive impairment in Alzheimer's disease (AD). Evidence demonstrates that tau positron emission tomography (PET) reliably identifies individuals at high risk for clinical progression.
The paper
Isabela Just de Jesus Vanni, João Pedro Ferrari‐Souza, Marco Antônio Albini Valer, Eduardo Rigon Zimmer
Show 20 more authors
Lorenzo Fontura Brasil Barcellos, Andrei Bieger, Douglas Teixeira Leffa, Guilherme Povala, Firoza Zubeida Lussier, Wagner Scheeren Brum, Cristiano Schaffer Aguzzoli, Anderson Silva Corin, Marco Antônio De Bastiani, Giovanna Carello‐Collar, Wyllians Vendramini Borelli, Nesrine Rahmouni, Joseph Therriault, Lydia Trudel, Arthur C. Macedo, Diogo O. Souza, Pâmela C.L. Ferreira, Bruna Bellaver, Pedro Rosa‐Neto, Tharick Ali Pascoal,Universidade Federal do Rio Grande do Sul
AAIC 2025 Abstract · 9 Jan 2026 · CC BY
Presented at AAIC 2025
